BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38524109)

  • 61. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
    Canfell K; Saville M; Caruana M; Gebski V; Darlington-Brown J; Brotherton J; Heley S; Castle PE
    BMJ Open; 2018 Jan; 8(1):e016700. PubMed ID: 29374658
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Accuracy of visual inspection with acetic acid in detecting high-grade cervical intraepithelial neoplasia in pre- and post-menopausal Thai women with minor cervical cytological abnormalities.
    Poomtavorn Y; Suwannarurk K
    Asian Pac J Cancer Prev; 2015; 16(6):2327-31. PubMed ID: 25824759
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Mexican Cervical Cancer Screening Trial: self-sampling for human papillomavirus with unaided visual inspection as a secondary screen.
    Belinson JL; Pretorius RG; Enerson C; Garcia F; Cruz EP; Belinson SE; Yeverino García E; Brainard J
    Int J Gynecol Cancer; 2009 Jan; 19(1):27-32. PubMed ID: 19258937
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Deep learning based cervical screening by the cross-modal integration of colposcopy, cytology, and HPV test.
    Fu L; Xia W; Shi W; Cao GX; Ruan YT; Zhao XY; Liu M; Niu SM; Li F; Gao X
    Int J Med Inform; 2022 Mar; 159():104675. PubMed ID: 34979436
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Can the careHPV test performed in mobile units replace cytology for screening in rural and remote areas?
    Lorenzi AT; Fregnani JH; Possati-Resende JC; Antoniazzi M; Scapulatempo-Neto C; Syrjänen S; Villa LL; Longatto-Filho A
    Cancer Cytopathol; 2016 Aug; 124(8):581-8. PubMed ID: 27070446
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnostic value of acetic acid comparing with conventional Pap smear in the detection of colposcopic biopsy-proved CIN.
    Hegde D; Shetty H; Shetty PK; Rai S
    J Cancer Res Ther; 2011; 7(4):454-8. PubMed ID: 22269409
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HPV detection-based cervical cancer screening program in low-resource setting: lessons learnt from a community-based demonstration project in India.
    Mittal S; Mandal R; Banerjee D; Das P; Ghosh I; Panda C; Biswas J; Basu P
    Cancer Causes Control; 2016 Mar; 27(3):351-8. PubMed ID: 26712612
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. University of Zimbabwe/JHPIEGO Cervical Cancer Project.
    Lancet; 1999 Mar; 353(9156):869-73. PubMed ID: 10093978
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Home-based urinary HPV DNA testing in women who do not attend cervical cancer screening clinics.
    Ducancelle A; Reiser J; Pivert A; Le Guillou-Guillemette H; Le Duc-Banaszuk AS; Lunel-Fabiani F
    J Infect; 2015 Sep; 71(3):377-84. PubMed ID: 25964233
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer.
    Jeronimo J; Bansil P; Valdez M; Kang LN; Zhao FH; Qiao YL; Chen W; Zhang X; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
    J Low Genit Tract Dis; 2015 Jul; 19(3):220-3. PubMed ID: 25279978
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Cervical cancer: Current situation and management in Morocco].
    Belglaiaa E; Mougin C
    Bull Cancer; 2019 Nov; 106(11):1008-1022. PubMed ID: 31606139
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HPV screening for cervical cancer in rural India.
    Sankaranarayanan R; Nene BM; Shastri SS; Jayant K; Muwonge R; Budukh AM; Hingmire S; Malvi SG; Thorat R; Kothari A; Chinoy R; Kelkar R; Kane S; Desai S; Keskar VR; Rajeshwarkar R; Panse N; Dinshaw KA
    N Engl J Med; 2009 Apr; 360(14):1385-94. PubMed ID: 19339719
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India.
    Shastri SS; Dinshaw K; Amin G; Goswami S; Patil S; Chinoy R; Kane S; Kelkar R; Muwonge R; Mahé C; Ajit D; Sankaranarayanan R
    Bull World Health Organ; 2005 Mar; 83(3):186-94. PubMed ID: 15798842
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers.
    Wentzensen N; Walker J; Smith K; Gold MA; Zuna R; Massad LS; Liu A; Silver MI; Dunn ST; Schiffman M
    Am J Obstet Gynecol; 2018 Jun; 218(6):604.e1-604.e8. PubMed ID: 29462629
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cervical Screening and Colposcopy Management of Women Age 24 and Under.
    Buick C; Jembere N; Wang L; Kupets R
    J Obstet Gynaecol Can; 2020 Dec; 42(12):1518-1524. PubMed ID: 32988802
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.
    Huchko MJ; Sneden J; Sawaya G; Smith-McCune K; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
    Int J Cancer; 2015 Jan; 136(2):392-8. PubMed ID: 24889387
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.
    Mayrand MH; Duarte-Franco E; Rodrigues I; Walter SD; Hanley J; Ferenczy A; Ratnam S; Coutlée F; Franco EL;
    N Engl J Med; 2007 Oct; 357(16):1579-88. PubMed ID: 17942871
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C; Batmaz G; Dane B; Cetin A
    Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Screening for cervical neoplasia in Bangladesh using visual inspection with acetic acid.
    Nessa A; Hussain MA; Rahman JN; Rashid MH; Muwonge R; Sankaranarayanan R
    Int J Gynaecol Obstet; 2010 Nov; 111(2):115-8. PubMed ID: 20674919
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Three-year follow-up results of visual inspection with acetic acid/Lugol's iodine (VIA/VILI) used as an alternative screening method for cervical cancer in rural areas].
    Zhang YZ; Ma JF; Zhao FH; Xiang XE; Ma ZH; Shi YT; Hu SY; Qiao YL
    Chin J Cancer; 2010 Jan; 29(1):4-8. PubMed ID: 20038302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.